Pro Medicus Limited (ASX:PME)
Australia flag Australia · Delayed Price · Currency is AUD
178.86
-4.85 (-2.64%)
Aug 14, 2026, 4:10 PM AEST

Pro Medicus Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Pro Medicus stock has a consensus rating of "Buy" and an average price target of $190.04. The average 1-year stock price forecast is 6.25% higher than the current stock price, while the lowest is $54.00 (-69.81%) and the highest is $250.00 (+39.77%).

Price Target: $190.04 (+6.25%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$54.00$190.04$200.00$250.00
Change-69.81%+6.25%+11.82%+39.77%

Analyst Ratings

The average analyst rating for Pro Medicus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy779977
Buy233333
Hold332244
Sell000000
Strong Sell111111
Total131415151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Macquarie
No rating
Macquarie
Buy
Maintains
$221.00$224.00
BuyMaintains$221.00$224.00+25.24%Jul 31, 2026
Jefferies
Jefferies
Hold
Maintains
$192.60$195.80
HoldMaintains$192.60$195.80+9.47%Jul 29, 2026
RBC Capital
RBC Capital
Hold
Maintains
$195.00$190.00
HoldMaintains$195.00$190.00+6.23%Jul 27, 2026
J.P. Morgan
J.P. Morgan
Hold
Downgrades
$203.70
HoldDowngrades$203.70+13.89%Jul 22, 2026
Citi
Citi
Buy
Maintains
$240.00
BuyMaintains$240.00+34.18%Jul 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
261.53M
from 212.98M
Increased by 22.80%
Revenue Next Year
334.40M
from 261.53M
Increased by 27.86%
EPS This Year
1.36
from 1.14
Increased by 19.47%
EPS Next Year
1.79
from 1.36
Increased by 31.72%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
68.06M93.46M124.90M161.50M212.98M261.53M
Revenue Growth
19.79%37.31%33.64%29.30%31.87%22.80%
Gross Profit
67.57M93.00M124.36M161.20M212.67M260.69M
Gross Margin
99.28%99.50%99.56%99.81%99.85%99.68%
Operating Income
42.63M61.31M84.08M112.79M157.79M202.33M
Net Income
30.85M44.44M60.65M82.79M115.22M241.61M
EPS
----1.141.36
EPS Growth
----49.48%19.47%
Forward PE
151.3882.65100.34151.89203.41131.45
Dividend / Share
0.150.220.300.400.550.76
Dividend Growth
25.00%46.67%36.36%33.33%37.50%37.42%
Free Cash Flow
24.00M42.34M46.18M69.20M91.53M130.91M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202620272028
High278.4M
Avg261.5M
Low253.6M

Revenue Growth

Revenue Growth202620272028
High
30.7%
Avg
22.8%
Low
19.1%

EPS Forecast

EPS202620272028
High1.44
Avg1.36
Low1.32

EPS Growth

EPS Growth202620272028
High
26.4%
Avg
19.5%
Low
16.2%